Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.68

-2.4%

Dec 12 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mike head who wrote (226)	6/15/1999 7:37:00 PM
From: scaram(o)uche	Read Replies (2) of 52153

Mike: I've been to Slough to do business with them twice. However, the first time was just after they had installed a novel new device, an "airlift" fermenter. It was too big for the building and was actually sticking through a hole in the roof. Some are now chuckling...... that was a long time ago. You track down the current projects, and I'll do my best to comment. Is Lonza a part of Celltech, or was it entirely spun out, etc., etc., etc. The anti-TNF collaboration with Bayer that went thud was a Chiron MAb, I believe. That may help as you start down your mucky path, as the project is probably still alive (on paper, if not in reality). Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next